2021 annual financial data
Neumora Therapeutics 2021 Operating cash flow growth
Direct answer
Operating cash flow growth was -181.84%.
Operating income was -237,323,000 USD and net income was -237,312,000 USD.
Operating cash flow was -75,420,000 USD.
Get free Neumora Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -237,323,000 USD
- Net income
- -237,312,000 USD
- Operating cash flow
- -75,420,000 USD